{"nct_id":"NCT06846320","title":"Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2025-04-29","start_date_type":"ACTUAL","primary_completion_date":"2026-11","primary_completion_date_type":"ESTIMATED","completion_date":"2026-11","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["ABBV"]}